Nonalcoholic fatty liver disease: is it all in the genes?
Dawn McDowell Torres, Stephen A. Harrison – 29 October 2010
Dawn McDowell Torres, Stephen A. Harrison – 29 October 2010
Martin Rössle, Daniel Grandt – 29 October 2010
Lei Wan, Chang‐Hai Tsai, Chin‐Moo Hsu, Chin‐Chang Huang, Chih‐Chao Yang, Chiu‐Chu Liao, Chin‐Ching Wu, Yu‐An Hsu, Cheng‐Chun Lee, Su‐Ching Liu, Wei‐De Lin, Fuu‐Jen Tsai – 29 October 2010 – Wilson disease is a copper metabolism disorder caused by mutations in ATP7B, a copper‐transporting adenosine triphosphatase. A molecular diagnosis was performed on 135 patients with Wilson disease in Taiwan.
Ian Guest, Zoran Ilic, Stewart Sell – 29 October 2010 – The age dependence of the oval cell response and bile duct carcinomas of male F344 rats exposed to a cyclic choline deficiency‐ethionine (CDE) diet (2 weeks on, 1 week off) supports the concept of loss of potential of liver stem cells to form cancers with aging. Livers of rats exposed at 3 weeks of age demonstrated a robust and widespread oval cell proliferation followed by cholangiofibrosis and bile duct metaplasia with extensive mucinous cysts throughout all lobes, and induction of cholangiocarcinomas (CCAs) in seven of eight rats.
Joanna D. Stewart, Rita Horvath, Enrico Baruffini, Iliana Ferrero, Stefanie Bulst, Paul B. Watkins, Robert J. Fontana, Christopher P. Day, Patrick F. Chinnery – 29 October 2010 – Sodium valproate (VPA) is widely used throughout the world to treat epilepsy, migraine, chronic headache, bipolar disorder, and as adjuvant chemotherapy. VPA toxicity is an uncommon but potentially fatal cause of idiosyncratic liver injury. Rare mutations in POLG, which codes for the mitochondrial DNA polymerase γ (polγ), cause Alpers‐Huttenlocher syndrome (AHS).
Jayant A. Talwalkar – 29 October 2010
Fumitaka Suzuki, Yoshiyuki Suzuki, Norio Akuta, Hitomi Sezaki, Miharu Hirakawa, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saito, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi, Kazuaki Chayama, Naoyuki Kamatani, Yusuke Nakamura, Yuzo Miyakawa, Hiromitsu Kumada – 29 October 2010 – Polymorphisms of the inosine triphosphatase (ITPA) gene influence anemia during pegylated interferon (PEG‐IFN) and ribavirin (RBV) therapy, but their effects during triple therapy with PEG‐IFN, RBV, and telaprevir are not known.
Ji Hoon Yu, Bing‐Mei Zhu, Mark Wickre, Gregory Riedlinger, Weiping Chen, Atsushi Hosui, Gertraud W. Robinson, Lothar Hennighausen – 29 October 2010 – Although the cytokine‐inducible transcription factor signal transducer and activator of transcription 5 (STAT5) promotes proliferation of a wide range of cell types, there are cell‐specific and context‐specific cases in which loss of STAT5 results in enhanced cell proliferation.
Karlin Raja Karlmark, Henning W. Zimmermann, Christoph Roderburg, Nikolaus Gassler, Hermann E. Wasmuth, Tom Luedde, Christian Trautwein, Frank Tacke – 29 October 2010 – Chemokines modulate inflammatory responses that are prerequisites for organ fibrosis upon liver injury. Monocyte‐derived hepatic macrophages are critical for the development, maintenance, and resolution of hepatic fibrosis.
Alain Braillon – 29 October 2010